The global Renal Biomarkers market is segmented on the basis of marker type, assay platform, application and geography. On the basis of marker type, the market is segmented into Creatinine, Blood urea nitrogen (BUN), Cystatin C, Neutrophil gelatinise-associated lipocalin (NGAL). It is further segmented into other markers such as N-Acetyl-?-D-Glucosaminidase (NAG), Kidney Injury Molecule 1 (Kim1), TIMP-2, L-FABP, Interleukin-18 and Clusterin. The market is segmented on the basis of assay platform type into, Enzyme Linked Immunosorbent Assay (ELISA) and Turbidimetric Immunoassay which includes Particle-Enhanced Turbidimetric Immunoassay (PETIA). The market further segments into other assay types such as Chemiluminescent Immunoassay (CLIA) and fluorescence immunoassay. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA.
Get Free Sample Report Of Renal Biomarkers Market @ http://www.marketresearchstore.com/report/world-renal-biomarkers-market-opportunities-and-forecasts-70992#RequestSample
Few of the strategies adopted by key industrial players are collaborations, FDA approvals and distribution agreements. For instance, recently, the International Society of Nephrology (ISN) with the support of industry players, has launched, 0by25, a human right initiative to neutralize the count of deaths arising from acute kidney injury, worldwide, by 2025. In Sep 2014, FDA approved Astute Medical’s NephroCheck, the first diagnostic test for acute kidney injury. The company also entered into a marketing and development agreement with BioMérieux, allowing the use of NephroCheck on VIDAS immunoassay system. The companies profiled in the report include, Abbott Diagnostics, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Siemens Healthcare Diagnostics Inc., Thermo Fisher Scientific Inc., Astute Medical Inc., Alere Inc., bioMérieux SA and Randox Laboratories Ltd.
Do Inquiry To Buy Report Of Renal Biomarkers Market @ http://www.marketresearchstore.com/report/world-renal-biomarkers-market-opportunities-and-forecasts-70992#InquiryForBuying
Global Renal Biomarkers Market – By Marker Type
- Creatinine
- Blood urea nitrogen (BUN)
- Cystatin C
- Neutrophil gelatinase-associated lipocalin (NGAL)
- Others
- N-Acetyl-?-D-Glucosaminidase (NAG)
- Kidney Injury Molecule 1 (Kim1)
- TIMP-2 (TIMP metallopeptidase inhibitor 2)
- Liver-Type Fatty Acid-Binding Protein (L-FABP)
- Interleukin-18 (IL-18)
- Clusterin
Global Renal Biomarkers Market – By Assay Platform Type
- Enzyme Linked Immunosorbent Assay (ELISA)
- Enzymatic Assay
- Turbidimetric Immunoassay
- Particle-Enhanced Turbidimetric Immunoassay (PETIA)
- Others
- Chemiluminescent Immunoassay (CLIA)
- Fluorescence Immunoassay
- Global Renal Biomarkers Market – By Application
- Diagnosis and disease progression monitoring
- Research
Global Renal Biomarkers Market – By Geography
- North America
- Europe
- Asia-Pacific
- LAMEA
Contact Us:
Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442, USA
USA Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: [email protected]
Web: http://www.marketresearchstore.com/
